India’s life sciences sector has been steadily expanding, driven by rising global demand for pharmaceuticals, increased research activity, and strong policy support for domestic manufacturing. With the country emerging as a key supplier of medicines and vaccines worldwide, there is growing focus on building advanced industrial ecosystems that can support innovation, large-scale production and global competitiveness.
Building on this momentum, a Rs 3,000-crore high-tech pharmaceutical park is set to come up at the Dighi Port Industrial Area, Maharashtra. Envisioned as an integrated life sciences hub, the project will bring pharmaceutical and biotechnology companies into a single ecosystem, supported by shared infrastructure, advanced utilities and dedicated R&D facilities to support innovation and large-scale production.
The proposed park will span around 1,000 hectares in Raigad district, covering parts of Mangaon and Roha talukas within the Dighi Port Industrial Area. The development will include industrial zones, commercial spaces, internal road networks, common utilities and planned open areas, creating a structured environment for life sciences manufacturing and allied activities.
The project moved forward after the Maharashtra Industrial Development Corporation (MIDC) signed a concession agreement with Maha Integrated Life Sciences City Limited (MILeS City), a wholly owned subsidiary of Ramky Infrastructure Limited, for the development of the high-tech pharmaceutical park.
The initiative will be implemented through a Public-Private Partnership (PPP) model under the Design, Build, Finance, Operate and Transfer (DBFOT) framework. The concession period will extend for 95 years, including a five-year construction phase during which the core infrastructure is expected to be developed.
Once operational, the park will support activities across the life sciences value chain. Planned facilities include advanced utilities, shared infrastructure, R&D centres, incubation hubs and technology transfer platforms aimed at encouraging collaboration and sectoral innovation. The infrastructure will also focus on environmental safety, regulatory compliance and sustainable industrial operations.
Under the agreement, MILeS City will oversee the development, operation, maintenance and management of the project throughout the concession period. The revenue framework will include land lease premiums, lease rentals, development charges and service fees for infrastructure and utilities.
The development is expected to attract investments into the pharmaceutical and biotechnology sectors while generating direct and indirect employment in the region, and supporting the growth of ancillary industries around the industrial area.
Following the agreement, the order book of Ramky Infrastructure Limited has reached around Rs 13,500 crore, reflecting its continued presence in large-scale infrastructure and industrial development projects.
Commenting on the development, Sunil S Nair, CEO of Ramky Infrastructure Limited, said the project would help build a strong life sciences ecosystem in the region.
“This agreement marks a significant milestone not only for industrial development but also for the communities and businesses that stand to benefit from it. By creating a large-scale integrated life sciences ecosystem at the Dighi Port Industrial Area, we aim to support employment generation, strengthen regional infrastructure, encourage innovation, and attract long-term investment into Maharashtra,” he said.
Got questions or experiences to share? Comment below or connect with me on Instagram @samuelmjosh and LinkedIn: https://www.linkedin.com/in/samuel-joshua-maddela-ab210b1b9
